Trends in the diagnosis and management of TTP: European perspective

Transfusion and Apheresis Science

Volumn 51, Issue 1, 2014, Pages 11-14

  Scully, Marie ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

ADAMTS 13; Plasma therapy; TTP; Viral inactivation

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CYCLOPHOSPHAMIDE; ENZYME ANTIBODY; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; METHYLENE BLUE; NONOXINOL 9; OCTAPLAS; PROTEIN S; TRITON X 100; TROPONIN T; UNCLASSIFIED DRUG; VINCRISTINE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE ANTIBODY;

ALLERGIC REACTION; ANEMIA; CLINICAL FEATURE; COMA; ECHOCARDIOGRAPHY; FEVER; HEADACHE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY INJURY; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTOPENIA; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSFUSION RELATED ACUTE LUNG INJURY; MORTALITY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; UNITED KINGDOM;

GREAT BRITAIN; HUMANS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84930029878     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.08.001     Document Type: Review

References (31)

1. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hithero undescribed disease. Proc N Y Pathol Soc 1924, 24:21-24.
2. Scully M., Yarranton H., Liesner R., Cavenagh J., Hunt B., Benjamin S., et al. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 2008, 142:819-826.
3. Hughes C., McEwan J.R., Longair I., Hughes S., Cohen H., Machin S., et al. Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13. J Thromb Haemost 2009, 7:529-536.
4. Coppo P., Wolf M., Veyradier A., Bussel A., Malot S., Millot G.A., et al. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol 2006, 132:66-74.
5. Kavanagh D., Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol 2010, 25:2431-2442.
6. Loirat C., Garnier A., Sellier-Leclerc A.L., Kwon T. Plasmatherapy in atypical hemolytic uremic syndrome. Semin Thromb Hemost 2010, 36:673-681.
7. Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C., et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991, 325:393-397.
8. Yarranton H., Lawrie A.S., Purdy G., MacKie I.J., Machin S.J. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med 2004, 14:39-44.
9. O'Shaughnessy D.F., Atterbury C., Bolton M.P., Murphy M., Thomas D., Yates S., et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004, 126:11-28.
10. de la Rubia R.J., Arriaga F., Linares D., Larrea L., Carpio N., Marty M.L., et al. Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. Br J Haematol 2001, 114:721-723.
11. Alvarez-Larran A., Del Rio J., Ramirez C., Albo C., Pena F., Campos A., et al. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sang 2004, 86:246-251.
12. Alvarez-Larran A., Rio-Garma J., Pujol M., de la Rubia J., Hernandez-Jodra M., Borrell M., et al. Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment. Ann Hematol 2009, 88(10):973-978.
13. del Rio-Garma J., Alvarez-Larran A., Martinez C., Muncunill J., Castella D., de la Rubia J., et al. Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol 2008, 143:39-45.
14. Pock K., Heger A., Janisch S., Svae T.E., Romisch J. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas). Transfus Apher Sci 2007, 37:223-231.
15. Cardigan R., Philpot K., Cookson P., Luddington R. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion 2009, 49:696-703.
16. Yarranton H., Lawrie A.S., MacKie I.J., Pinkoski L., Corash L., Machin S.J. Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. Transfusion 2005, 45:1453-1458.
17. Mintz P.D., Neff A., Mackenzie M., Goodnough L.T., Hillyer C., Kessler C., et al. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion 2006, 46:1693-1704.
18. Solheim B.G., Rollag H., Svennevig J.L., Arafa O., Fosse E., Bergerud U. Viral safety of solvent/detergent-treated plasma. Transfusion 2000, 40:84-90.
19. Hellstern P., Solheim B.G. The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma. Transfus Med Hemother 2011, 38:65-70.
20. Lawrie A.S., Green L., Canciani M.T., MacKie I.J., Peyvandi F., Scully M.A., et al. The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables. Vox Sang 2010, 99:232-238.
21. Neisser-Svae A., Bailey A., Gregori L., Heger A., Jordan S., Behizad M., et al. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. Vox Sang 2009, 97:226-233.
22. Harrison C.N., Lawrie A.S., Iqbal A., Hunter A., Machin S.J. Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura. Br J Haematol 1996, 94:756-758.
23. Yarranton H., Cohen H., Pavord S.R., Benjamin S., Hagger D., Machin S.J. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 2003, 121:778-785.
24. Scully M., Longair I., Flynn M., Berryman J., Machin S.J. Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang 2007, 93:154-158.
25. Reutter J.C., Sanders K.F., Brecher M.E., Jones H.G., Bandarenko N. Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura. J Clin Apher 2001, 16:134-138.
26. Flesland O., Seghatchian J., Solheim B.G. The Norwegian Plasma Fractionation Project - a 12 year clinical and economic success story. Transfus Apher Sci 2003, 28:93-100.
27. Chekrizova V., Murphy W.G. Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies. Transfus Med 2006, 16:85-91.
28. Williamson L.M., Llewelyn C.A., Fisher N.C., Allain J.P., Bellamy M.C., Baglin T.P., et al. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 1999, 39:1227-1234.
29. Horowitz M.S., Pehta J.C. SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sang 1998, 74(Suppl. 1):231-235.
30. Sinnott P., Bodger S., Gupta A., Brophy M. Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet 2004, 31:271-274.
31. Dichtelmuller H.O., Biesert L., Fabbrizzi F., Gajardo R., Groner A., von Hoege I., et al. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2009, 49:1931-1943.